secwatch.observer — SEC 8-K summary
======================================

Issuer:     OMNICELL, INC. (OMCL)
CIK:        0000926326
Form:       8-K
Filed at:   2026-02-05T23:59:59+00:00
Accession:  0000926326-26-000003
Event type: earnings
Sentiment:  neutral
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Omnicell Q4 rev $314M (+2% YoY), GAAP net loss $0.05/sh; FY26 revenue guide $1.215-1.255B
--------------------------------------------------------------------------------

- Q4 total revenues $314M (+2% YoY); full-year 2025 rev $1.185B (+7% YoY).
- GAAP net loss Q4 $2M ($0.05 diluted loss) vs net income $16M ($0.34) in Q4 2024.
- Non-GAAP net income Q4 $18M ($0.40) vs $28M ($0.60) YoY; FY25 non-GAAP EPS $1.62.
- FY2025 product bookings $535M (-4% YoY); ARR $635.6M (+9.6%); product backlog $640.3M.
- Launched Titan XT dispensing system at ASHP Midyear; guides FY26 rev $1.215-1.255B, Non-GAAP EBITDA $145-160M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/926326/000092632626000003/0000926326-26-000003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/926326/000092632626000003/omcl-20260205.htm
  HTML page:      https://secwatch.observer/filing/0000926326-26-000003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer